VA's Pharmacy Prime Vendor Contract Awarded to McKesson Corporation for $34.4M in FY2015
Contract Overview
Contract Amount: $34,408,631 ($34.4M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2015-09-01
End Date: 2015-09-30
Contract Duration: 29 days
Daily Burn Rate: $1.2M/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 5
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2015SEPT NCO 20
Place of Performance
Location: VANCOUVER, CLARK County, WASHINGTON, 98660
Plain-Language Summary
Department of Veterans Affairs obligated $34.4 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2015SEPT NCO 20 Key points: 1. The contract, valued at $34.4 million, was awarded to McKesson Corporation. 2. This represents a significant award within the pharmaceutical preparation manufacturing sector. 3. The contract was awarded under full and open competition, suggesting a competitive bidding process. 4. The short duration (29 days) might indicate a specific, time-bound need or a bridge contract.
Value Assessment
Rating: good
The contract's firm fixed price structure suggests clear cost expectations. Benchmarking against similar large-scale pharmaceutical supply contracts would be necessary for a definitive value assessment, but the award amount appears reasonable for a prime vendor role.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The award was made under full and open competition, indicating that multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and ensures the government receives fair market value.
Taxpayer Impact: The competitive nature of this award likely resulted in a favorable price for taxpayers, ensuring efficient use of funds for essential pharmaceutical supplies.
Public Impact
Ensures timely access to pharmaceuticals for veterans. Supports the operational needs of the Department of Veterans Affairs healthcare system. Contributes to the stability of pharmaceutical supply chains. Impacts patient care by ensuring medication availability.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Short contract duration raises questions about long-term strategy.
- Lack of specific product details limits granular cost analysis.
Positive Signals
- Awarded under full and open competition.
- Firm fixed price contract provides cost certainty.
Sector Analysis
This contract falls within the Pharmaceutical Preparation Manufacturing sector, a critical area for healthcare. Spending benchmarks for prime vendor contracts of this nature can vary widely based on the scope of services and the specific pharmaceuticals managed.
Small Business Impact
The data does not indicate whether small businesses were involved as subcontractors or partners in this specific award. Further analysis would be needed to determine the extent of small business participation.
Oversight & Accountability
The award was managed by the Department of Veterans Affairs, which has established procurement oversight processes. The use of a delivery order under a larger contract framework suggests adherence to existing regulations.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Short contract duration.
- Limited detail on specific services and products.
- Potential for price fluctuations in pharmaceutical markets.
- Dependence on a single large vendor for critical supplies.
Tags
pharmaceutical-preparation-manufacturing, department-of-veterans-affairs, wa, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $34.4 million to MCKESSON CORPORATION. EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2015SEPT NCO 20
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $34.4 million.
What is the period of performance?
Start: 2015-09-01. End: 2015-09-30.
What is the typical duration for Pharmacy Prime Vendor contracts, and does this short duration indicate a specific circumstance?
Pharmacy Prime Vendor contracts often have longer durations, typically spanning multiple years, to ensure consistent supply chain management and vendor commitment. A 29-day duration is unusually short and may suggest this was a bridge contract to cover a gap, a specific project-based need, or a limited-time requirement. Further investigation into the contract's history and purpose is warranted.
How does McKesson Corporation's pricing for this contract compare to industry benchmarks for similar pharmaceutical prime vendor services?
Without detailed line-item pricing and specific service scope, a precise benchmark comparison is challenging. However, McKesson is a major player in pharmaceutical distribution. The firm fixed price and full and open competition suggest a market-driven price. A comprehensive analysis would require comparing the total award value against the volume and types of pharmaceuticals procured and the services rendered, relative to other large-scale VA or government pharmaceutical contracts.
What is the potential impact on veteran healthcare access if this contract was not competitively bid or if pricing was suboptimal?
If this contract were not competitively bid or if pricing were suboptimal, veteran healthcare access could be negatively impacted through potential drug shortages, increased costs for the VA (leading to reduced services elsewhere), or delays in medication delivery. Full and open competition, as indicated here, mitigates these risks by fostering a competitive environment that typically drives down costs and ensures reliable service delivery.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 5
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: ONE POST ST, SAN FRANCISCO, CA, 94104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $34,408,631
Exercised Options: $34,408,631
Current Obligation: $34,408,631
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: VA797P12D0001
IDV Type: IDC
Timeline
Start Date: 2015-09-01
Current End Date: 2015-09-30
Potential End Date: 2015-09-30 00:00:00
Last Modified: 2019-08-20
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)